4//SEC Filing
Lochner Daniel 4
Accession 0001209191-22-059938
CIK 0001720725other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 8:50 AM ET
Size
5.4 KB
Accession
0001209191-22-059938
Insider Transaction Report
Form 4
Lochner Daniel
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2022-12-01$11.20/sh−3,258$36,490→ 74,463 total
Footnotes (1)
- [F1]The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the non-reportable vesting and settlement of restricted stock units (the "RSUs"). Such RSUs were previously reported on the Reporting Person's Form 4 as to (i) 11,222 filed with the Securities and Exchange Commission on February 2, 2021 (the "2021 Award"); and (ii) 19,500 filed with the Securities and Exchange Commission on January 11, 2022 (the "2022 Award"). 2,805 RSUs of the 2021 Award and 4,875 RSUs of the 2022 Award were subsequently accelerated, effective December 1, 2022, resulting in the withholding being reported herein.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001791187
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 8:50 AM ET
- Size
- 5.4 KB